Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase

Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase

US Patent 6593305 · Granted Jul 15, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of interleukin 17E for the treatment of cancer2012
2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatm2012
Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses ther2011
Antitumor antisense sequences directed against R1 and R2 components of ribonucle2008
Oligonucleotides from the untranslated regions of housekeeping genes and methods2007
Neuropilin antisense oligonucleotide sequences and methods of using same to modu2006
Antisense oligonucleotide sequences as inhibitors of microorganisms2003
Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase 2003
Suppression of malignancy utilizing ribonucleotide reductase R12002
Insulin-like growth factor II antisense oligonucleotide sequences and methods of2002
Antitumor antisense sequences directed against R1 and R2 components of ribonucle2000
Antitumor antisense sequences directed against ribonucleotide reductase1999